Maven Securities’s West Pharmaceutical WST Stock Holding History

Maven Securities’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,553	Closed	-$2.05M	–	429
2019 Q3	$2.05M	Buy	+14,553	New	+$2M	0.65%	39

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Maven Securities's WST Position: Q4 2019 in Review

Maven Securities sold out of West Pharmaceutical (WST) in Q4 2019, closing a stake of 14,553 shares — an estimated $2.05M sold.

Maven Securities first reported a position in WST in Q3 2019 and held it in 1 quarter. The position peaked at $2.05M in Q3 2019. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

Maven Securities reported no remaining West Pharmaceutical position as of Q4 2019 after selling out during the quarter.
Maven Securities sold 14,553 West Pharmaceutical shares in Q4 2019, an estimated $2.05M.
Maven Securities first reported a position in West Pharmaceutical in Q3 2019 and held it in 1 quarter.
Maven Securities's West Pharmaceutical position peaked at $2.05M in Q3 2019.
445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on Maven Securities's 13F filing for Q4 2019, filed 14 Feb 2020.